171 related articles for article (PubMed ID: 37194711)
21. Promoter/enhancer-based controllability of regulatory networks.
Devkota P; Wuchty S
Sci Rep; 2022 Mar; 12(1):3528. PubMed ID: 35241702
[TBL] [Abstract][Full Text] [Related]
22. Super-Enhancers and Their Parts: From Prediction Efforts to Pathognomonic Status.
Vasileva AV; Gladkova MG; Ashniev GA; Osintseva ED; Orlov AV; Kravchuk EV; Boldyreva AV; Burenin AG; Nikitin PI; Orlova NN
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542080
[TBL] [Abstract][Full Text] [Related]
23. Integrative modeling reveals key chromatin and sequence signatures predicting super-enhancers.
Khan A; Zhang X
Sci Rep; 2019 Feb; 9(1):2877. PubMed ID: 30814546
[TBL] [Abstract][Full Text] [Related]
24. scGRN: a comprehensive single-cell gene regulatory network platform of human and mouse.
Huang X; Song C; Zhang G; Li Y; Zhao Y; Zhang Q; Zhang Y; Fan S; Zhao J; Xie L; Li C
Nucleic Acids Res; 2024 Jan; 52(D1):D293-D303. PubMed ID: 37889053
[TBL] [Abstract][Full Text] [Related]
25. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
26. ENdb: a manually curated database of experimentally supported enhancers for human and mouse.
Bai X; Shi S; Ai B; Jiang Y; Liu Y; Han X; Xu M; Pan Q; Wang F; Wang Q; Zhang J; Li X; Feng C; Li Y; Wang Y; Song Y; Feng K; Li C
Nucleic Acids Res; 2020 Jan; 48(D1):D51-D57. PubMed ID: 31665430
[TBL] [Abstract][Full Text] [Related]
27. RegPrecise 3.0--a resource for genome-scale exploration of transcriptional regulation in bacteria.
Novichkov PS; Kazakov AE; Ravcheev DA; Leyn SA; Kovaleva GY; Sutormin RA; Kazanov MD; Riehl W; Arkin AP; Dubchak I; Rodionov DA
BMC Genomics; 2013 Nov; 14():745. PubMed ID: 24175918
[TBL] [Abstract][Full Text] [Related]
28. Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma.
Zhou J; Toh SH; Tan TK; Balan K; Lim JQ; Tan TZ; Xiong S; Jia Y; Ng SB; Peng Y; Jeyasekharan AD; Fan S; Lim ST; Ong CJ; Ong CK; Sanda T; Chng WJ
Mol Cancer; 2023 Apr; 22(1):69. PubMed ID: 37032358
[TBL] [Abstract][Full Text] [Related]
29.
Song C; Zhang Y; Huang H; Wang Y; Zhao X; Zhang G; Yin M; Feng C; Wang Q; Qian F; Shang D; Zhang J; Liu J; Li C; Tang H
Mol Ther Nucleic Acids; 2023 Sep; 33():655-667. PubMed ID: 37637211
[No Abstract] [Full Text] [Related]
30. LRH1-driven transcription factor circuitry for hepatocyte identity: Super-enhancer cistromic analysis.
Joo MS; Koo JH; Kim TH; Kim YS; Kim SG
EBioMedicine; 2019 Feb; 40():488-503. PubMed ID: 30638865
[TBL] [Abstract][Full Text] [Related]
31. Super-enhancers delineate disease-associated regulatory nodes in T cells.
Vahedi G; Kanno Y; Furumoto Y; Jiang K; Parker SC; Erdos MR; Davis SR; Roychoudhuri R; Restifo NP; Gadina M; Tang Z; Ruan Y; Collins FS; Sartorelli V; O'Shea JJ
Nature; 2015 Apr; 520(7548):558-62. PubMed ID: 25686607
[TBL] [Abstract][Full Text] [Related]
32. Contribution of transposable elements and distal enhancers to evolution of human-specific features of interphase chromatin architecture in embryonic stem cells.
Glinsky GV
Chromosome Res; 2018 Mar; 26(1-2):61-84. PubMed ID: 29335803
[TBL] [Abstract][Full Text] [Related]
33. ModEx: A text mining system for extracting mode of regulation of transcription factor-gene regulatory interaction.
Farahmand S; Riley T; Zarringhalam K
J Biomed Inform; 2020 Feb; 102():103353. PubMed ID: 31857203
[TBL] [Abstract][Full Text] [Related]
34. The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.
Li XP; Qu J; Teng XQ; Zhuang HH; Dai YH; Yang Z; Qu Q
Int J Biol Sci; 2023; 19(4):1036-1048. PubMed ID: 36923930
[TBL] [Abstract][Full Text] [Related]
35. [Research progress of super enhancer in cancer].
Wu ZQ; Mi ZY
Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
[TBL] [Abstract][Full Text] [Related]
36. Systematic analysis of enhancer regulatory circuit perturbation driven by copy number variations in malignant glioma.
Xiao J; Jin X; Zhang C; Zou H; Chang Z; Han N; Li X; Zhang Y; Li Y
Theranostics; 2021; 11(7):3060-3073. PubMed ID: 33537074
[No Abstract] [Full Text] [Related]
37. Super-enhancers and novel therapeutic targets in colorectal cancer.
Liu Q; Guo L; Lou Z; Xiang X; Shao J
Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
[TBL] [Abstract][Full Text] [Related]
38. Superenhancer-transcription factor regulatory network in malignant tumors.
Liang Y; Li L; Xin T; Li B; Zhang D
Open Med (Wars); 2021; 16(1):1564-1582. PubMed ID: 34722892
[TBL] [Abstract][Full Text] [Related]
39. dbCoRC: a database of core transcriptional regulatory circuitries modeled by H3K27ac ChIP-seq signals.
Huang M; Chen Y; Yang M; Guo A; Xu Y; Xu L; Koeffler HP
Nucleic Acids Res; 2018 Jan; 46(D1):D71-D77. PubMed ID: 28977473
[TBL] [Abstract][Full Text] [Related]
40. Super-enhancers: Asset management in immune cell genomes.
Witte S; O'Shea JJ; Vahedi G
Trends Immunol; 2015 Sep; 36(9):519-26. PubMed ID: 26277449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
